Ventyx Biosciences Inc.

VTYX | NASDAQ

Price Alert Chart Builder DCF Calculator

$14

$0 (0.00%)

At close: Mar 6, 2026, 9:30 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.00%

(1D)

Rating

Updated: Feb 20, 2026

14.5

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1B

1D Range

14 14

52W Range

0.78 25

Valuation (TTM)

PE -9.33

PB 5.25

EV/EBITDA -7.23

Valuation (NTM)

Forward PE N/A

Forward PEG 1.35

Price Target $26.78

Cash Flow

FCF Yield -8.8%

SBC Adj. FCF Yield -10.7%

SBC Impact -22.1%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 33.8% | -0.8%

FCF 3Y | 5Y 27.3% | -21.6%

Returns

ROA -36.5%

ROE -36.6%

ROIC -41.9%

Financial Health

Net Cash

$192.64M

Current Ratio 17.86

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidat...

Sector Healthcare

Industry Biotechnology

Employees 81

IPO Date Oct 20, 2021

Website www.ventyxbio.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$14

Upside

0.00%

Buy (0)

Hold (5)

Sell (0)

Analyst Details ➞